EFFICACY AND SAFETY OF PD-1/PD-L1 INHIBITORS USED IN THE TREATMENT OF PATIENTS WITH ADVANCED AND METASTATIC MELANOMA - A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS

被引：0
作者：
Verma, J. [1 ]
Verma, D. [1 ]
Maria, A. [1 ]
机构：
[1] VRB Analyt Pvt Ltd, Thana, MH, India
来源：
VALUE IN HEALTH | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN154
引用
收藏
页码：S50 / S50
页数：1
相关论文
共 50 条
[21]   Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors combined with chemoradiotherapy for locally advanced rectal cancer: a systematic review and meta-analysis [J].
Yu, Jiaojiao ;
Wang, Zhijing ;
Li, Mingxu ;
Zhu, Hua ;
Tang, Xiaoxia ;
Luan, Ke ;
Zhi, Yinhuan ;
Yin, Shan ;
Su, Yuanqi ;
Long, Jingyan ;
He, Qubo ;
Quan, Jieru ;
Li, Chenchen .
FRONTIERS IN PHARMACOLOGY, 2025, 16
[22]   Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis [J].
Xiao Zhang ;
Zhengyang Yang ;
Yongbo An ;
Yishan Liu ;
Qi Wei ;
Fengming Xu ;
Hongwei Yao ;
Zhongtao Zhang .
World Journal of Surgical Oncology, 20
[23]   Clinical benefits of PD-1/PD-L1 inhibitors in patients with metastatic colorectal cancer: a systematic review and meta-analysis [J].
Zhang, Xiao ;
Yang, Zhengyang ;
An, Yongbo ;
Liu, Yishan ;
Wei, Qi ;
Xu, Fengming ;
Yao, Hongwei ;
Zhang, Zhongtao .
WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
[24]   Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis [J].
Wen, Wen ;
Zhang, Yong ;
Zhang, Hua ;
Chen, Yingshuang .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (03) :969-978
[25]   Comparative efficacy and safety of PD-1 versus PD-L1 inhibitors in breast cancer treatment: A systematic review and meta analysis [J].
Xie, Xintong ;
Chen, Lingzhu ;
Kong, Xiangyi ;
Huo, Yujia ;
Huang, Weiyuan ;
Huang, Junjie ;
Zhang, Lin ;
Jiang, Hongnan ;
Gao, Jidong .
INTERNATIONAL JOURNAL OF CANCER, 2025, 156 (10) :1936-1949
[26]   Clinical outcomes of PD-1/PD-L1 inhibitors in patients with advanced hepatocellular carcinoma: a systematic review and meta-analysis [J].
Wen Wen ;
Yong Zhang ;
Hua Zhang ;
Yingshuang Chen .
Journal of Cancer Research and Clinical Oncology, 2023, 149 :969-978
[27]   Efficacy and safety of neoadjuvant PD-1 inhibitors or PD-L1 inhibitors for muscle invasive bladder cancer: a systematic review and meta-analysis [J].
Huang, Shibo ;
Huang, Yanping ;
Li, Chunyan ;
Liang, Yiwen ;
Huang, Miaoyan ;
Luo, Raoshan ;
Liang, Weiming .
FRONTIERS IN IMMUNOLOGY, 2024, 14
[28]   PD-L1 expression as biomarker of efficacy of PD-1/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: A systematic review and meta-analysis [J].
Khan, Muhammad ;
Du, Kunpeng ;
Ai, Meiling ;
Wang, Baiyao ;
Lin, Jie ;
Ren, Anbang ;
Chen, Chengcong ;
Huang, Zhong ;
Qiu, Wenze ;
Yuan, Yawei ;
Tian, Yunhong .
FRONTIERS IN IMMUNOLOGY, 2023, 14
[29]   PD-1/PD-L1 Inhibitors Monotherapy for the Treatment of Endometrial Cancer: Meta-Analysis and Systematic Review [J].
Dai, Yun ;
Muaibati, Munawaer ;
Xie, Weiming ;
Abasi, Abuduyilimu ;
Li, Kexin ;
Tong, Qing ;
Zhang, Tao ;
Meng, Yifan ;
Zhuang, Liang ;
Huang, Xiaoyuan .
CANCER INVESTIGATION, 2022, 40 (03) :293-309
[30]   Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis [J].
Song, Dandan ;
Hou, Shufu ;
Ma, Ning ;
Yan, Bing ;
Gao, Jing .
FRONTIERS IN IMMUNOLOGY, 2024, 15
12345